285 related articles for article (PubMed ID: 22750309)
21. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
Nakajima M; Terao T; Iwata N; Nakamura J
Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
[TBL] [Abstract][Full Text] [Related]
22. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
[TBL] [Abstract][Full Text] [Related]
23. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
24. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia.
Ko YH; Jung SW; Joe SH; Lee CH; Jung HG; Jung IK; Kim SH; Lee MS
Psychoneuroendocrinology; 2007 May; 32(4):385-91. PubMed ID: 17395394
[TBL] [Abstract][Full Text] [Related]
25. Association of biomarkers and depressive symptoms in schizophrenia.
Noto CS; Gadelha A; Belangero SI; Smith MA; de Aguiar BW; Panizzuti B; Mari Jde J; Gama CS; Bressan RA; Brietzke E
Neurosci Lett; 2011 Nov; 505(3):282-5. PubMed ID: 22044873
[TBL] [Abstract][Full Text] [Related]
26. Predictors of quality of life in inpatients with schizophrenia.
Fujimaki K; Morinobu S; Yamashita H; Takahashi T; Yamawaki S
Psychiatry Res; 2012 May; 197(3):199-205. PubMed ID: 22370148
[TBL] [Abstract][Full Text] [Related]
27. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
Henkel V; Mergl R; Schäfer M; Rujescu D; Möller HJ; Hegerl U
Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894
[TBL] [Abstract][Full Text] [Related]
28. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
29. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
[TBL] [Abstract][Full Text] [Related]
30. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
31. Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia.
Fervaha G; Agid O; Takeuchi H; Lee J; Foussias G; Zakzanis KK; Graff-Guerrero A; Remington G
Schizophr Res; 2015 Feb; 161(2-3):351-6. PubMed ID: 25471015
[TBL] [Abstract][Full Text] [Related]
32. Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics.
Weisbard JJ; Pardo M; Pollack S
Psychopharmacol Bull; 1997; 33(1):119-22. PubMed ID: 9133762
[TBL] [Abstract][Full Text] [Related]
33. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study.
Krivoy A; Weizman A; Laor L; Hellinger N; Zemishlany Z; Fischel T
Eur Neuropsychopharmacol; 2008 Feb; 18(2):117-21. PubMed ID: 17728110
[TBL] [Abstract][Full Text] [Related]
34. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
35. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
Lee BH; Kim YK
Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
[TBL] [Abstract][Full Text] [Related]
36. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
[TBL] [Abstract][Full Text] [Related]
37. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
[TBL] [Abstract][Full Text] [Related]
38. Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study.
Zhang Y; Tang Z; Ruan Y; Huang C; Wu J; Lu Z; Li W; Tang Y; Liu J; She J; Wang TT; Zhu Y; Teng ZW; Zeng Y
Med Sci Monit; 2018 Dec; 24():9136-9143. PubMed ID: 30554232
[TBL] [Abstract][Full Text] [Related]
39. [Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients--a preliminary 10-week open-label study].
Strzelecki D; Kropiwnicki P; Rabe-Jabłońska J
Psychiatr Pol; 2013; 47(4):609-20. PubMed ID: 24946468
[TBL] [Abstract][Full Text] [Related]
40. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
